NCT05707312 is a clinical trial in Endometrial Cancer, sponsored by Clinica Universidad de Navarra, Universidad de Navarra.

Who is sponsoring NCT05707312?

NCT05707312 is sponsored by Clinica Universidad de Navarra, Universidad de Navarra.

What condition does NCT05707312 study?

NCT05707312 studies Endometrial Cancer, Lymph Node Metastasis, Sentinel Lymph Node.

Is NCT05707312 still recruiting?

NCT05707312 is currently status unknown. Last updated 31 January 2023.

Last reviewed 2023-01-31 · How we verify

NCT05707312

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Staging Endometrial caNcer Based on molEcular ClAssification

Status unknown Last updated 31 January 2023

What this trial tests

trial in Endometrial Cancer in 1,032 participants. Status unknown.

Timeline

1 January 2023

Primary endpoint
30 September 2023

31 December 2023

Quick facts

Lead sponsor	Clinica Universidad de Navarra, Universidad de Navarra
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	1,032
Start date	1 January 2023
Primary completion	30 September 2023
Estimated completion	31 December 2023
Sites	1 location across Spain

Conditions studied

Endometrial Cancer — all drugs for Endometrial Cancer →
Lymph Node Metastasis — all drugs for Lymph Node Metastasis →
Sentinel Lymph Node — all drugs for Sentinel Lymph Node →

Sponsor

Clinica Universidad de Navarra, Universidad de Navarra

Who can join

18 and older, female only, with Endometrial Cancer or Lymph Node Metastasis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The SENECA study tries to evaluate the rate of lymph node involvement depending on the molecular subgroup in early-stage endometrial cancer (I/II) patients undergoing surgery as part of their treatment.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Low-Volume Metastases in Apparent Early-Stage Endometrial Cancer: Prevalence, Clinical Significance, and Future Perspectives.
Fumagalli D, De Vitis LA, Caruso G, Occhiali T, et al · · 2024 · cited 7× · PMID 38611016 · DOI 10.3390/cancers16071338
Sentinel Lymph Node Assessment in Endometrial Cancer: A Review.
Clark C, Loizzi V, Cormio G, Lopez S. · · 2024 · cited 3× · PMID 39335173 · DOI 10.3390/cancers16183202

Verify or expand the search:

Other recruiting trials for Endometrial Cancer

Currently open trials in the same condition.

NCT07419841 — A Phase 1 Study of the Safety and Tolerability of CTX-10726 · Phase 1 · recruiting
NCT07382583 — Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the P · recruiting
NCT07377734 — Intrauterine Injection of Type III Collage in FST of EC/AEH · Phase 2 · recruiting
NCT07319429 — Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular Classification · Phase 2, PHASE3 · recruiting
NCT07397624 — Endoscopic Suture Gastroplasty (ESG) for Treatment of Obese Patients With Endometrial Cancer · recruiting

Other Clinica Universidad de Navarra, Universidad de Navarra trials

Trials by the same sponsor.

NCT07370571 — NO AXILLARY SURGERY IN EARLY BREAST CANCER (OXIGENATE) · not yet recruiting
NCT07165431 — Effect of a Postbiotic Supplementation in Overweight and Obese Subjects: A Randomized Controlled Trial (PARABIOTICS-2). · NA · recruiting
NCT07447440 — Role of Pro-Resolving Lipid Mediators in Obesity-Associated Diseases · recruiting
NCT07191210 — Co-Designed Comprehensive Transition Programme for First-Line Nurse Managers · NA · not yet recruiting
NCT07132060 — MRI-guided Dose Intensification Program Locally Advanced Pancreatic Cancer · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05707312 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Clinica Universidad de Navarra, Universidad de Navarra
Last refreshed: 31 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05707312.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing